Fresenius Medical Care AG (ETR: FME)

Market Cap	11.97B
Revenue (ttm)	19.24B
Net Income (ttm)	658.94M
Shares Out	293.41M
EPS (ttm)	2.25
PE Ratio	18.17
Forward PE	12.52
Dividend	1.19 (2.92%)
Ex-Dividend Date	n/a

Volume	69,453
Open	41.10
Previous Close	40.80
Day's Range	41.10 - 41.89
52-Week Range	32.51 - 42.60
Beta	0.86
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2024

About Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1996
• Employees: 119,845
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: FME

Financial Performance

In 2023, Fresenius Medical Care AG's revenue was 19.45 billion, an increase of 0.29% compared to the previous year's 19.40 billion. Earnings were 499.00 million, a decrease of -25.90%.